X2 BioCruise with New York Bio

Nataliya Katsnelson joined the NJ/NY biotechnology community during major networking dinner cruise in New York.

On the photo: Kamala Maddali, Vice President, Biopharma Collaborations and Companion Diagnostics at Cancer Genetics (on the left); Nataliya Katsnelson, Business Development Manager, Global Clinical Trials (on the right)

Last week Nataliya Katsnelson joined the NJ/NY biotechnology community during major networking dinner cruise in New York. Apart from presenting GCT capabilities and services in Central and Eastern Europe, she made new fruitful connections with other participants and exchanged valuable experience in the field of clinical trials.

The event was organized by New York Bio, BioNJ and New X2.

You can learn more about the event here.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.